- Home
- CRC vs VKTX Comparison
CRC vs VKTX Comparison
Compare CRC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRC
- VKTX
- Stock Information
- Founded
- CRC 2014
- VKTX 2012
- Country
- CRC United States
- VKTX United States
- Employees
- CRC N/A
- VKTX N/A
- Industry
- CRC Oil & Gas Production
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CRC Energy
- VKTX Health Care
- Exchange
- CRC Nasdaq
- VKTX Nasdaq
- Market Cap
- CRC 5.5B
- VKTX 5.6B
- IPO Year
- CRC N/A
- VKTX 2015
- Fundamental
- Price
- CRC $56.82
- VKTX $49.21
- Analyst Decision
- CRC Strong Buy
- VKTX Strong Buy
- Analyst Count
- CRC 11
- VKTX 12
- Target Price
- CRC $65.45
- VKTX $106.75
- AVG Volume (30 Days)
- CRC 554.8K
- VKTX 3.7M
- Earning Date
- CRC 11-05-2024
- VKTX 02-05-2025
- Dividend Yield
- CRC 2.46%
- VKTX N/A
- EPS Growth
- CRC 11.09
- VKTX N/A
- EPS
- CRC 6.96
- VKTX N/A
- Revenue
- CRC $2,592,000,000.00
- VKTX N/A
- Revenue This Year
- CRC $11.89
- VKTX N/A
- Revenue Next Year
- CRC $10.50
- VKTX N/A
- P/E Ratio
- CRC $8.16
- VKTX N/A
- Revenue Growth
- CRC N/A
- VKTX N/A
- 52 Week Low
- CRC $43.09
- VKTX $17.23
- 52 Week High
- CRC $60.41
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- CRC 51.98
- VKTX 37.72
- Support Level
- CRC $52.54
- VKTX $47.50
- Resistance Level
- CRC $57.50
- VKTX $52.58
- Average True Range (ATR)
- CRC 1.67
- VKTX 2.44
- MACD
- CRC -0.44
- VKTX 0.09
- Stochastic Oscillator
- CRC 56.79
- VKTX 19.55
About CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.